Islet antigen-specific T cell clones in autoimmune diabetes: From mice to men

Diabetes/Metabolism Reviews

Volumn 13, Issue 3, 1997, Pages 127-138

  Schloot, Nanette C ^a   Roep, Bart O ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; T LYMPHOCYTE ANTIGEN;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN SPECIFICITY; AUTOIMMUNITY; CELL CLONING; CELL TRANSFER; CONTROLLED STUDY; DIABETES MELLITUS; ETIOLOGY; HELPER CELL; HUMAN; IN VITRO STUDY; INSULITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ANIMALS; AUTOANTIGENS; AUTOIMMUNE DISEASES; CLONE CELLS; DIABETES MELLITUS, TYPE 1; HUMANS; ISLETS OF LANGERHANS; MICE; T-LYMPHOCYTES;

ANIMALIA;

EID: 0030924123     PISSN: 07424221     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0895(199709)13:3<127::AID-DMR192>3.0.CO;2-A     Document Type: Review

References (94)

1. Like AA, Kislauskis E, Williams RM, and Rossini AA: Neonatal thymectomy prevents spontaneous diabetes mellitus in BB/W rat. Science 216: 644-646, 1982.
2. Chatenoud L, Thervet E, Primo J, and Bach JF: Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc Natl Acad Sci USA 91: 123-127, 1994.
3. Shizuru JA, Taylor-Edwards C, Banks BA, Gregory AK, and Fathman CG: Immunotherapy of the nonobese diabetic mouse: Treatment with an antibody to T-helper lymphocytes. Science 240: 659-662, 1988.
4. Hutchings P, Oreilly L, Parish NM, Waldmann H, and Cooke A: The use of a nondepleting anti-CD4 monoclonal antibody to re-establish tolerance to beta cells in NOD mice. Eur J Immunol 22: 1913-1918, 1992.
5. Hutchings PR, Simpson E, O'Reilly LA, Lund T, Waldmann H, and Cooke A: The involvement of Ly2+ T cells in beta cell destruction. J Autoimmun 3 (Suppl. 1): 101-109, 1990.
6. Wicker LS, Miller BJ, and Mullen Y: Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes 35: 855-860, 1986.
7. Peterson JD, Pike B, McDuffie M, and Haskins K: Islet-specific T cell clones transfer diabetes to nonobese diabetic (NOD) FL mice. J Immunol 153: 2800-2806, 1994.
8. Christianson SW, Shultz LD, and Leiter EH: Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice: Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-thy-la donors. Diabetes 42: 44-55, 1993.
9. Serreze DV, Leiter EH, Worthen SM, and Shultz LD: NOD marrow stem cells adoptively transfer diabetes to resistant (NOD × NON) F1 mice. Diabetes 37: 252-255, 1988.
10. Bendelac A, Carnaud C, Boitard C, and Bach JF: Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates: Requirement for both L3T4+ and Lyt-2+ T cells. J Exp Med 166: 823-832, 1987.
11. Stiller CR, Dupre J, Gent M, Jenner MR, Keown PA, Laupacis A, Martell R, Rodger NW, von Graffeuried B, and Wolfe BM: Effects of cyclosporin immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science 223: 1362-1367, 1984.
12. Bougneres PF, Carel JC, Castano L, Boitard C, Gardin JP, Landais P, Hors J, Mihatsch MJ, Paillard M, Chaussain JL et al: Factors associated with early remission of type I diabetes in children treated with cyclosporine. N Engl J Med 318: 663-670, 1988.
13. Roep BO: Perspectives in diabetes: T-cell responses to islet autoantigens in insulin-dependent diabetes mellitus. The search for the Holy Grail. Diabetes 45: 1147-1156, 1996.
14. Stegall MD, Lafferty KJ, Kam I, and Gill RG: Evidence of recurrent autoimmunity in human allogeneic islet transplantation. Transplantation 61: 1272-1274, 1996.
15. Santamaria P, Nakhleh RE, Sutherland DE, and Barbosa JJ: Characterization of T lymphocytes infiltrating human pancreas allograft affected by isletitis and recurrent diabetes. Diabetes 41: 53-61, 1992.
16. Lampeter EF, Homberg M, Quabeck K, Schaefer UW, Wernet P, Bertrams J, Grosse-Wilde H, Gries FA, and Kolb H: Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet 341: 1243-1244, 1993.
17. Tisch R, and McDevitt H: Insulin-dependent diabetes mellitus. Cell 89: 290-297, 1996.
18. Steinman L: Escape from "horror autotoxicus": Pathogenesis and treatment of autoimmune disease. [Review] Cell 80: 7-10, 1995.
19. Hanahan D, Jolicoeur C, Alpert S, and Skowronski J: Alternative self or nonself recognition of an antigen expressed in a rare cell type in transgenic mice: Implications for self-tolerance and autoimmunity. Cold Spring Harbor Symp Quant Biol 54 Pt 2: 821-835, 1989.
20. Jolicoeur C, Hanahan D, and Smith KM: T-cell tolerance toward a transgenic beta-cell antigen and transcription of endogenous pancreatic genes in thymus. Proc Natl Acad Sci USA 91: 6707-6711, 1994.
21. Schloot N, Daniel D, and Wegmann D: Limiting dilution analysis of islet infiltrating and peripheral T cells in prediabetic NOD mice. Diabetologia 37 (Suppl. 1): A94, 1994.
22. Wegmann DR, Gill RG, Norbury-Glaser M, Schloot N, and Daniel D: Analysis of the spontaneous T cell response to insulin in NOD mice. J Autoimmun 7: 833-843, 1994.
23. Haskins K, and Wegmann D: Diabetogenic T-cell clones. Diabetes 45: 1299-1305, 1996.
24. Haskins K, Portas M, Bergman B, Lafferty K, and Bradley B: Pancreatic islet-specific T-cell clones from nonobese diabetic mice. Proc Natl Acad Sci USA 86: 8000-8004, 1989.
25. Daniel D, Gill RG, Schloot N, and Wegmann D: Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from nod mice. Eur J Immunol 25: 1056-1062, 1995.
26. Schloot NC, Roep BO, Wegmann D, Yu L, Chase HP, Wang T, and Eisenbark GS: Altered immune response to insulin in newly diagnosed versus insulin treated patients and healthy control subjects. Diabetologia 40: 564-572.
27. Durinovic-Bello I, Hummel M, and Ziegler AG: Cellular immune response to diverse islet cell antigens in IDDM. Diabetes 45: 795-800, 1996.
28. Roep BO, Duinkerken G, Schreuder GM, Kolb H, de Vries RR, and Martin S: HLA-associated inverse correlation between T cell and antibody responsiveness to islet autoantigen in recentonset insulin-dependent diabetes mellitus. Eur J Immunol 26: 1285-1289, 1996.
29. Hanninen A, Jalkanen S, Salmi M, Toikkanen S, Nikolakaros G, and Simell O: Macrophages, T-cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus. J Clin Invest 90: 1901-1910, 1992.
30. Santamaria P, Lewis C, Jessurun J, Sutherland DE, and Barbosa JJ: Skewed T-cell receptor usage and junctional heterogeneity among isletitis alpha beta and gamma delta T-cells in human IDDM. [Corrected. Published erratum appears in Diabetes 43(7): 954, 1994] Diabetes 43: 599-606, 1994.
31. Conrad B, Weidmann E, Trucco G, Rudert WA, Behboo R, Ricordi C, Rodriguez-Rilo H, Finegold D, and Trucco M: Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature 371: 351-355, 1994.
32. Lundin KE, Scott H, Hansen T, Paulsen G, Halstensen TS, Fausa O, Thorsby E, and Sollid LM: Gliadin-specific, HLA-DQ(alpha 1*0501, beta 1* 0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 178: 187-196, 1993.
33. Gjertsen HA, Sollid LM, Ek J, Thorsby E, and Lundin KE: T cells from the peripheral blood of coeliac disease patients recognize gluten antigens when presented by HLA-DR, -DQ, or -DP molecules. Scand J Immunol 39: 567-574, 1994.
34. Paliard X, West SG, Lafferty JA, Clements JR, Kappler JW, Marrack P, and Kotzin BL: Evidence for the effects of a superantigen in rheumatoid arthritis. Science 253: 325-329, 1991.
35. Kaufman DL, Clare-Salzler MJ, Tian JD, Forsthuber T, Ting GS, Robinson P, Atkinson MA, Sercarz EE, Tobin AJ, and Lehmann PV: Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366: 69-72, 1993.
36. Tian J, Atkinson MA, Clare-Salzler M, Herschenfeld A, Forsthuber T, Lehmann PV, and Laufman DL: Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med 183: 1561-1567, 1996.
37. Roep BO, Kallan AA, Duinkerken G, Arden SD, Hutton JC, Bruining GJ, and de Vries RR: T-cell reactivity to beta-cell membrane antigens associated with beta-cell destruction in IDDM. Diabetes 44: 278-283, 1995.
38. Atkinson MA, Bowman MA, Campbell L, Darrow BL, Kaufman DL, and Maclaren NK: Cellular immunity to a determinant common to glutamate decarboxylase and Coxsackie virus in insulin-dependent diabetes. J Clin Invest 94: 2125-2129, 1994.
39. Adibzadeh M, Pohla H, Rehbein A, and Pawelec G: Long-term culture of monoclonal human T lymphocytes: models for immunosenescence? Mech Ageing Dev 83: 171-183, 1995.
40. Kallan AA, de Vries RR, and Roep BO: T-cell recognition of beta-cell autoantigens in insulin-dependent diabetes mellitus. [Review] APMIS 104: 3-11, 1996.
41. Schloot NC, Daniel D, Norbury-Glaser M, and Wegmann DR: Peripheral T cell clones from NOD mice specific for GAD65 peptides: Lack of islet responsiveness or diabetogenicity. J Autoimmun 9: 357-363, 1996.
42. Wegmann DR: The immune response to islets in experimental diabetes and insulin-dependent diabetes mellitus. Curr Opin Immunol 8: 860-864, 1996.
43. van Noort JM, van Sechel AC, Bajramovic JJ, el Ouagmiri M, Polman CH, and Lassmann H: The small heat-shock protein alpha b-crystallin as candidate autoantigen in multiple sclerosis. Nature 375: 798-801, 1995.
44. Arden SD, Roep BO, Neophytou PI, Usac EF, Duinkerken G, de Vries RR, and Hutton JC: Imogen 38: A novel 38-kd islet mitochondrial autoantigen recognized by T cells from a newly diagnosed type 1 diabetic patient. J Clin Invest 97: 551-561, 1996.
45. Elias D, Markovits D, Reshef T, Van der Zee R, and Cohen IR: Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein. Proc Natl Acad Sci USA 87: 1576-1580, 1990.
46. Hohlfeld R, and Engel AG: Expression of 65kD heat-shock proteins in the inflammatory myopathies. Ann Neurol 32: 821-623, 1992.
47. Yang XD, and Fiege U: Heat-shock proteins in autoimmune diabetes: From causative antigen to specific therapy. Experientia 48: 650-565, 1992.
48. Taswell C: Limiting dilution assays for the determination of immunocompetent cell frequencies. J Immunol 126: 1614-1619, 1981.
49. Haskins K, and McDuffie M: Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone. Science 249: 1433-1436, 1990.
50. Healey D, Ozegbe P, Arden SD, Chandler P, Hutton JC, and Cooke A: In vivo activity and in vivo specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice. J Clin Invest 95: 2979-2985, 1995.
51. Roep BO, Arden SD, De Vries RRP, and Hutton JC: T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins. Nature 345: 632-634, 1990.
52. Kallan AA, Roep BO, Arden SD, Hutton JC, and De Vries RRP: Beta-cell reactive T-cell clones from type 1 diabetes patients are not beta cell specific and recognize multiple antigens. J Autoimmun 8: 877-899, 1995.
53. Neophytou PI, Muir EM, and Hutton JC: A subtractive cloning approach to the identification of mRNAs specifically expressed in pancreatic β-cells. Diabetes 45: 127-133, 1996.
54. Neophytou PI, Roep BO, Arden SD, Muir EI, Duinkerken G, Kallan AA, de Vries RR, and Hutton JC: T-cell epitope analysis using subtracted expression libraries (TEASEL): Application to a 38-kDa autoantigen recognized by T-cells from an insulin-dependent diabetic patient. Proc Natl Acad Sci USA 93: 2014-2018, 1996.
55. Dallas-Pedretti A, McDuffie M, and Haskins K: A diabetes-associated T-cell autoantigen maps to a telomeric locus on mouse chromosome 6. Proc Natl Acad Sci USA 92: 1386-1390, 1995.
56. Waiden P: T-cell epitope determination. Curr Opin Immunol 8: 68-74, 1996.
57. Gundlach BJ, Wiesmüller KH, Junt T, Kienle S, Jung G, and Walden P: Determination of T cell epitopes with random peptide libraries. J Immunol Meth 192: 149-155, 1996.
58. Wallny HJ, Deres K, Faath S, Jung G, Van Pel A, Boon T, and Rammensee HG: Identification and quantification of a naturally presented peptide as recognized by cytotoxic T lymphocytes specific for an immunogenic tumor variant. Int Immunol 4: 1085-1090, 1992.
59. Cohen IR, and Elias D: Immunity to 60 kDa heat shock protein in autoimmune diabetes. Diabetes Nutr Metab 9: 229-232, 1996.
60. Schloot N, Gottlieb P, and Wegmann D: Characterization of diabetogenic, GAD65-specific T cell clones established from NOD mice. Diabetes 45: A 307, 1996.
61. Daniel D, and Wegmann DR: Protection of nonobese diabetic mice from diabgtes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc Natl Acad Sci USA 93: 956-960, 1996.
62. Lohmann T, Leslie RDG, and Londei M: T-cell clones to epitopes of glutamic acid decarboxylase 65 raised from normal subjects and patients with insulin-dependent diabetes. J Autoimmun 9: 385-389, 1996.
63. Wicker LS, Chen SL, Nepom GT, Elliott JF, Freed DC, Bansal A, Zheng S, Herman A, Lernmark A, Zoller DM, Peterson LB, Rothbard JB, Cummings R, and Whiteley PJ: Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401. J Clin Invest 98: 2597-2603, 1996.
64. Endl J, Otto H, Jung G, Dreisbusch B, Donié F, Stahl P, Elbracht R, Schmitz G, Meinl E, Hummel M, Ziegler AG, Wank R, and Schendel DJ: Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients. J Clin Invest 99: 2405-2415, 1997.
65. Kolb H, Kolb-Bachofen V, and Roep BO: Autoimmune versus inflammatory type 1 diabetes: A controversy? Immunol Today 16: 170-172, 1995.
66. Katz JD, Benoist C, and Mathis D: T helper cell subsets in insulin-dependent diabetes. Science 268: 1185-1188, 1995.
67. Katz JD, Benoist C, and Mathis D: T helper cell subsets in insulin-dependent diabetes. Science 268: 1185-1188, 1996.
68. Akhtar I, Gold JP, Pan LY, Ferrara JL, Yang XD, Kim JI, and Tan KN: CD4+ beta islet cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice. J Exp Med 182: 87-97, 1995.
69. Harrison LC, Honeyman MC, De Aizpurua HJ, Schmidli RS, Colman PG, Tait BD, and Crom DS: Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 341: 1365-1369, 1993.
70. Douglas Petersen L, Duinkerken G, Bruining GJ, van Lier RAW, De Vries RRP, and Roep BO: Increased numbers of in vivo activated T cells in patients with recent onset insulin-dependent diabetes mellitus. J Autoimmun 9: 731-737, 1996.
71. Ellis TM, and Atkinson MA: The clinical significance of an autoimmune response against glutamic acid decarboxylase. Nature Med 2: 148-153, 1996.
72. Tian J, Lehmann PV, and Kaufman DL: T cell cross-reactivity between coxsackievirus and glutamate decarboxylase is associated with a murine diabetes susceptibility allele. J Exp Med 180: 1979-1984, 1994.
73. Schloot NC, Roep BO, Wegmann DR, Yu L, Wang T, and Eisenbarth GS: T-cell reactivity of GAD65 peptide sequences shared with coxsackie virus protein in recent onset IDDM, post onset IDDM patients and control subjects. Diabetologia 40: 332-338, 1997.
74. Buschard K, Madsbad S, and Rygaard J: Passive transfer of diabetes mellitus from man to mouse. Lancet 1(8070) 908-910, 1978.
75. Calcinaro F, Hao LM, Chase HP, Klingensmith G, and Lafferty KJ: Detection of cell-mediated immunity in Type-1 diabetes mellitus. J Autoimmun 5: 137-147, 1992.
76. Petersen JS, Marshall MO, Baekkeskov S, Hejnaes KR, Hoiermadsen M, and Dyrberg T: Transfer of type-1 (insulin-dependent) diabetes mellitus associated autoimmunity to mice with severe combined immunodeficiency (SCID). Diabetologia 36: 510-515, 1993.
77. Serreze DV, Leiter EH, Hanson MS, Christianson SW, Shultz LD, Hesselton RM: Emv30null NOD-scid mice: An improved host for adoptive transfer of autoimmune diabetes and growth of human lymphohematopoietic cells. Diabetes 44: 1392-1398, 1995.
78. Kong YM, Lomo LC, Motte RW, Giraldo AA, Baisch J, Strauss G, Hämmerling GJ, and David CS: HLA-DRB1 polymorphism determines susceptibility to autoimmune thyroiditis in transgenic mice: Definitive association with HLA-DRB1*0301 (DR3) gene. J Exp Med 184: 1167-1172, 1996.
79. Daniel D, and Wegmann D: Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc Natl Acad Sci USA 93: 956-960, 1996.
80. Gerlin JC, Serreze DV, Christianson SW, and Leiter EH: Intrathymic islet cell transplantation reduces beta-cell autoimmunity and prevents diabetes in NOD/Lt mice. Diabetes 41: 1672-1676.
81. Elias D, and Cohen IR: Treatment of autoimmune diabetes and insulitis in NOD mice with heat shock protein 60 peptide p277. Diabetes 44: 1132-1138, 1995.
82. Clare-Salzler M, and Mullen Y: Marked dendritic cell-T cell cluster formation in the pancreatic lymph node of the non-obese diabetic mouse. Immunology 76: 478-484, 1992.
83. Prud'homme GJ, Long TY, Bocarro DC, Balderas RS, and Theofilopoulos AN: Analysis of pancreas-infiltrating T-cells in diabetic NOD mice: fusion with BW5147 yields a high frequency of islet-reactive hybridomas. Autoimmunity 10: 285-289, 1991.
84. Reich EP, Sherwin RS, Kanagawa O, and Janeway CA, Jr: An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes. Nature 341: 326-328, 1989.
85. Utsugi T, Yoon J-W, Park B, Imamura M, Averill N, Kawazu S, and Soutomenia P: Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse derived β-cell cytotoxic CD8+ T-cell clones in vivo. Diabetes 45: 1121-1131, 1996.
86. Wong FS, Visintin I, Wen L, Flavell RA, and Janeway CA: CD8 T-cell clones from young Nonobese Diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in absence of CD4 cells. J Exp Med 183: 67-76, 1996.
87. Durinovic-Bello I, Steinle A, Ziegler AG, and Schendel DJ: HLA-DQ-restricted, islet-specific T-cell clones of a type 1 diabetic patient: T-cell receptor sequence similarities to insulitis-inducing T-cells of nonobese diabetic mice. Diabetes 43: 1318-1325, 1994.
88. Kontiainen S, James RL, and Feldmann M: Human islet cell induced T cell lines and clones from diabetic children. Autoimmunity 8: 193-197, 1991.
89. Peakman M, Wen L, Mcnab GL, Watkins PJ, Tan KC, and Vergani D: T cell clones generated from patients with type 1 diabetes using interleukin-2 proliferate to human islet antigens. Autoimmunity 17: 31-39, 1994.
90. Miller GG, Pollack MS, Nell LJ, and Thomas JW: Insulin-specific human T cells. J Immunol 139: 3622-3629, 1987.
91. Ito Y, Nieda M, Uchigata Y, Nishimura M, Tokunaga K, Kuwata S, Obata F, Tadokoro K, Hirata K, Omori Y et al.: Recognition of human insulin in the context of HLA-DRB1*0406 products by T-cells of insulin autoimmune syndrome patients and healthy donors. J Immunol 151: 5770-5776, 1993.
92. Naquet P, Ellis J, Singh B, Hodges RS, and Delovitch TL: Processing and presentation of insulin. I. Analysis of immunogenic peptides and processing requirements for insulin A loop-specific T cells. J Immunol 139: 3955-3963, 1987.
93. Bach JM, Otto H, Jung G, Nepom G, Boitard C, and van Endert PM: Presentation of autoantigenic (GAD65) peptide in IDDM by an HLA allele protecting from disease. Hum Immunol 47: 151, 1996.
94. Panina-Bordignon P, Lang R, van Endert PM, Benazzi E, Felix AM, Pastore RM, Spina SGA, and Sinigaglia F: Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes. J Exp Med 181: 1923-1927, 1995.